Successful rechallenge with anti-tumor necrosis factor alpha for psoriatic arthritis after development of demyelinating nervous system disease during initial treatment: comment on the article by Mohan et al.

作者信息

Cisternas Marcela, Gutiérrez Miguel, Jacobelli Sergio

出版信息

Arthritis Rheum. 2002 Nov;46(11):3107-8; author reply 3108-9. doi: 10.1002/art.10488.

DOI:10.1002/art.10488

PMID:12428265

Abstract

摘要

相似文献

Successful rechallenge with anti-tumor necrosis factor alpha for psoriatic arthritis after development of demyelinating nervous system disease during initial treatment: comment on the article by Mohan et al.

Arthritis Rheum. 2002 Nov;46(11):3107-8; author reply 3108-9. doi: 10.1002/art.10488.

Pulmonary sarcoidosis in a patient with psoriatic arthritis during infliximab therapy.

Dermatol Online J. 2010 May 15;16(5):16.

Guideline for anti-TNF-alpha therapy in psoriatic arthritis.

Rheumatology (Oxford). 2005 Mar;44(3):390-7. doi: 10.1093/rheumatology/keh514. Epub 2005 Feb 3.

Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists.

Am J Med. 2005 May;118(5):552-6. doi: 10.1016/j.amjmed.2005.01.028.

[Recommendations for the appropriate use of anti-TNFalpha therapy in patients with psoriatic arthritis. Italian Rheumatology Society].

Reumatismo. 2004 Jul-Sep;56(3):133-4, 136-8.

Healing of psoriatic skin lesions, and improvement of psoriatic arthritis resistant to immunosuppressive drugs, after infliximab treatment.

Ann Rheum Dis. 2005 Nov;64(11):1665-7. doi: 10.1136/ard.2005.036178.

Efficacy and safety of infliximab for the treatment of psoriatic arthritis.

Nat Clin Pract Rheumatol. 2006 Jun;2(6):300-1. doi: 10.1038/ncprheum0209.

Vasculitis, vitiligo, thyroiditis, and altered hormone levels after anti-tumor necrosis factor therapy.

J Rheumatol. 2011 Mar;38(3):579-80. doi: 10.3899/jrheum.100968.

Report of an additional case of anti-tumor necrosis factor therapy and Listeria monocytogenes infection: comment on the letter by Glück et al.

Arthritis Rheum. 2003 Jun;48(6):1764-5; author reply 1765-6. doi: 10.1002/art.11019.

Intra-articular infliximab in patients with rheumatoid arthritis and psoriatic arthritis with monoarthritis resistant to local glucocorticoids. Clinical efficacy extended to patients on systemic anti-tumour necrosis factor alpha.

Ann Rheum Dis. 2008 Dec;67(12):1787-90. doi: 10.1136/ard.2008.091900.

引用本文的文献

Neurological Side Effects of TNF-α Inhibitors Revisited: A Review of Case Reports.

Medicina (Kaunas). 2024 Aug 28;60(9):1409. doi: 10.3390/medicina60091409.

Management of Uveitis Patients on Anti-TNF Agents Who Develop Demyelinating Disease - A Case Series.

J Ophthalmic Inflamm Infect. 2024 Jul 30;14(1):35. doi: 10.1186/s12348-024-00403-3.

Sixteen syndrome: a rare presentation of central demyelination.

BMJ Case Rep. 2023 Jan 10;16(1):e250440. doi: 10.1136/bcr-2022-250440.

Front Neurol. 2022 Sep 29;13:1003270. doi: 10.3389/fneur.2022.1003270. eCollection 2022.

CNS Demyelination with TNF-α Blockers.

Curr Neurol Neurosci Rep. 2017 Apr;17(4):36. doi: 10.1007/s11910-017-0742-1.

Neurological and Neuropsychiatric Adverse Effects of Dermatologic Medications.

CNS Drugs. 2016 Dec;30(12):1149-1168. doi: 10.1007/s40263-016-0392-x.

Demyelinizing Neurological Disease after Treatment with Tumor Necrosis Factor-α Antagonists.

Case Rep Ophthalmol. 2016 Jul 11;7(2):345-53. doi: 10.1159/000447086. eCollection 2016 May-Aug.

Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy.

Cochrane Database Syst Rev. 2015 Mar 4;2015(3):CD003217. doi: 10.1002/14651858.CD003217.pub5.

Neurological adverse events in patients receiving anti-TNF therapy: a prospective imaging and electrophysiological study.

Arthritis Res Ther. 2014 Jun 17;16(3):R125. doi: 10.1186/ar4582.

Demyelinating Disease following Anti-TNFa Treatment: A Causal or Coincidental Association? Report of Four Cases and Review of the Literature.

Case Rep Neurol Med. 2013;2013:671935. doi: 10.1155/2013/671935. Epub 2013 May 16.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验